Coexistence of SARS-CoV-2 and cerebrovascular diseases: does COVID-19 positivity trigger cerebrovascular pathologies?

dc.authoridOzbek, hanefi/0000-0002-8084-7855
dc.authoridDOGAN, Mustafa/0000-0002-3341-925X
dc.authoridKaraarslan, Numan/0000-0001-5590-0637
dc.authoridYILMAZ, Ibrahim/0000-0003-2003-6337
dc.authorwosidOzbek, hanefi/O-3472-2019
dc.contributor.authorAtes, Ozkan
dc.contributor.authorYilmaz, Ibrahim
dc.contributor.authorKaraarslan, Numan
dc.contributor.authorErsoz, Emel
dc.contributor.authorKasim, Fatma Bahar Hacioglu
dc.contributor.authorDogan, Mustafa
dc.contributor.authorÖzbek, Hanefi
dc.date.accessioned2023-03-22T19:47:22Z
dc.date.available2023-03-22T19:47:22Z
dc.date.issued2022
dc.departmentBelirleneceken_US
dc.description.abstractThe objectives of this study were to determine the prevalence of cerebrovascular diseases caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, and to assess the pharmacological agents used in such cases as reported in the literature. Patient files were retrospectively scanned to determine the prevalence of neurological symptoms of the central nervous system (headache, dizziness, lack of smell and taste, numbness in arms and legs, change in consciousness, muscle weakness, loss of urine and stool control) and cerebrovascular diseases (ischemic cerebrovascular diseases, cerebral venous sinus thrombosis, intracerebral hemorrhage, subarachnoid/subdural hemorrhage) in 2019 novel coronavirus (2019-nCoV) disease (COVID-19) cases (n = 20,099). The diagnostic laboratory, radiology examinations and treatments applied to these cases were recorded. The data from studies presenting cerebrovascular diseases associated with SARS-Cov-2, which constituted 0.035% of all cases, were systematically evaluated from electronic databases. During the treatment of cerebrovascular diseases, it was discovered that high doses of enoxaparin sodium anti-Xa are combined with apixaban or acetylsalicylic acid or clopidogrel or piracetam, and mannitol, in addition to SARS-CoV-2 treatment modalities. While neurological symptoms of the central nervous system are uncommon in cases of SARS-CoV-2 infection, cerebrovascular diseases are far less common, according to the findings of this study. Acute cerebral ischemia was discovered to be the most common cerebrovascular disease associated with SARS-CoV-2. The mortality rate increases with the association between SARS-CoV-2 and cerebrovascular disease.en_US
dc.identifier.doi10.3855/jidc.15800
dc.identifier.endpage+en_US
dc.identifier.issn1972-2680
dc.identifier.issue6en_US
dc.identifier.pmid35797292en_US
dc.identifier.scopus2-s2.0-85134320811en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage981en_US
dc.identifier.urihttps://doi.org/10.3855/jidc.15800
dc.identifier.urihttps://hdl.handle.net/20.500.14034/661
dc.identifier.volume16en_US
dc.identifier.wosWOS:000825225800009en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherJ Infection Developing Countriesen_US
dc.relation.journalJournal Of Infection In Developing Countriesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject2019-nCoven_US
dc.subjectischemic cerebrovascular diseasesen_US
dc.subjectintracerebral hemorrhageen_US
dc.subjectpharmacological treatment protocolsen_US
dc.subjectSARS-CoV-2en_US
dc.subjectInfectionen_US
dc.titleCoexistence of SARS-CoV-2 and cerebrovascular diseases: does COVID-19 positivity trigger cerebrovascular pathologies?en_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Coexistence of SARS-CoV-2 and cerebrovascular diseases does COVID-19 positivity trigger cerebrovascular pathologies.pdf
Boyut:
8.3 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin / Full text